the final choice of treatment. In a recent survey on upwards, by Gleeson's chosen classification of deserved a mention in Rubens and colleagues' the mnageent flarngea caner inthe nite stag) ca be ured2 Not only is this clearly brief discussion of the treatment of myeloma, in Kingdom and Ontario, Canada, Gaze etal afound contrary to his statement that "Others present with preference to trials of high dose chemotherapy that 84% of otolaryngologists and 96% of clinical advanced disease, and for these unlucky patients with bone marrow transplantation, which are at oncologists would recommend primary radio-total laryngectomy provides the only hope of long present too small or in which long term follow up is therapy for T3,N0,M0 laryngeal cancer.'~term survival" but analysis of "salvage" surgery-insufficient to determine outcome. MultipleThe